Sanofi in talks to sell Zentiva arm to Advent

Sorin Melenciuc 17/04/2018 | 13:17

French healthcare group Sanofi said on Tuesday it is in exclusive talks to sell its Zentiva generics drugs subsidiary to private equity firm Advent International for EUR 1.9 billion, according to Reuters.

Zentiva operates in 50 markets, but has a strong presence especially in the Czech Republic, Slovakia and Romania, where it is the market leader.

Zentiva owns in Romania a generics drugs factory (previously named Sicomed).

The generic drugs portfolio of Zentiva includes cardiovascular and gastrointestinal drugs as well as painkillers and anti-inflammatory drugs based on ibuprofen and leflunomide molecules.

BR Magazine | Latest Issue

Download PDF or read online: September 2022 Issue | Business Review Magazine

The September 2022 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “Transilvania Investments paves its way to a sustainable
Sorin Melenciuc | 21/09/2022 | 14:17

You will receive a download link for the latest issue of Business Review Magazine in PDF format, based on the completion of the form below.

I agree with the Privacy policy of
I agree with the storage and handling of my data by

Close ×

We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

Accept & continue